chr2-218339752-G-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015488.5(PNKD):c.237-31G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0036 in 1,386,824 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.018   (  77   hom.,  cov: 31) 
 Exomes 𝑓:  0.0019   (  59   hom.  ) 
Consequence
 PNKD
NM_015488.5 intron
NM_015488.5 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.0670  
Publications
1 publications found 
Genes affected
 PNKD  (HGNC:9153):  (PNKD metallo-beta-lactamase domain containing) This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 2-218339752-G-T is Benign according to our data. Variant chr2-218339752-G-T is described in ClinVar as Benign. ClinVar VariationId is 260659.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0589  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PNKD | NM_015488.5 | c.237-31G>T | intron_variant | Intron 2 of 9 | ENST00000273077.9 | NP_056303.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0175  AC: 2655AN: 152004Hom.:  77  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2655
AN: 
152004
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00442  AC: 1087AN: 246196 AF XY:  0.00321   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1087
AN: 
246196
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00188  AC: 2326AN: 1234702Hom.:  59  Cov.: 17 AF XY:  0.00158  AC XY: 985AN XY: 625354 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2326
AN: 
1234702
Hom.: 
Cov.: 
17
 AF XY: 
AC XY: 
985
AN XY: 
625354
show subpopulations 
African (AFR) 
 AF: 
AC: 
1759
AN: 
28948
American (AMR) 
 AF: 
AC: 
148
AN: 
44230
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
24656
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
38452
South Asian (SAS) 
 AF: 
AC: 
8
AN: 
81214
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53112
Middle Eastern (MID) 
 AF: 
AC: 
16
AN: 
5324
European-Non Finnish (NFE) 
 AF: 
AC: 
186
AN: 
906032
Other (OTH) 
 AF: 
AC: 
208
AN: 
52734
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.496 
Heterozygous variant carriers
 0 
 125 
 251 
 376 
 502 
 627 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 56 
 112 
 168 
 224 
 280 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0175  AC: 2663AN: 152122Hom.:  77  Cov.: 31 AF XY:  0.0171  AC XY: 1271AN XY: 74366 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2663
AN: 
152122
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
1271
AN XY: 
74366
show subpopulations 
African (AFR) 
 AF: 
AC: 
2523
AN: 
41474
American (AMR) 
 AF: 
AC: 
95
AN: 
15268
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10614
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
19
AN: 
67980
Other (OTH) 
 AF: 
AC: 
24
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 125 
 249 
 374 
 498 
 623 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 28 
 56 
 84 
 112 
 140 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
12
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jun 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.